Isoflavones: Chemistry, analysis, functions and effects on health and cancer

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 17, 2014, Pages 7001-7010

  Ko, Kwang Pil ^a  

^a Gachon University College of Medicine   (South Korea)

Author keywords

Cancer prevention; Chemistry; Health effect; Isoflavone; Quantification

Indexed keywords

ISOFLAVONE DERIVATIVE;

CARDIOVASCULAR DISEASES; CHEMISTRY; DIABETES MELLITUS, TYPE 2; FEMALE; HUMAN; MALE; NEOPLASMS; OSTEOPOROSIS, POSTMENOPAUSAL;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; ISOFLAVONES; MALE; NEOPLASMS; OSTEOPOROSIS, POSTMENOPAUSAL;

EID: 84907267787     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.17.7001     Document Type: Review

References (78)

1. Adlercreutz H, Bannwart C, Wahala K, et al (1993). Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem Mol Biol, 44, 147-53.
2. Adlercreutz H, Hockerstedt K, Bannwart C, et al (1987). Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG). J Steroid Biochem, 27, 1135-44.
3. Arora A, Nair MG, Strasburg GM (1998). Antioxidant activities of isoflavones and their biological metabolites in a liposomal system. Arch Biochem Biophys, 356, 133-41.
4. Atmaca A, Kleerekoper M, Bayraktar M, et al (2008). Soy isoflavones in the management of postmenopausal osteoporosis. Menopause, 15, 748-57.
5. Barnes S (2010). The biochemistry, chemistry and physiology of the isoflavones in soybeans and their food products. Lymphat Res Biol, 8, 89-98.
6. Berrino F, Bellati C, Secreto G, et al (2001). Reducing bioavailable sex hormones through a comprehensive change in diet: the diet and androgens (DIANA) randomized trial. Cancer Epidemiol Biomarkers Prev, 10, 25-33.
7. Bolanos R, Del Castillo A, Francia J (2010). Soy isoflavones versus placebo in the treatment of climacteric vasomotor symptoms: systematic review and meta-analysis. Menopause, 17, 660-6.
8. Breinholt V, Larsen JC (1998). Detection of weak estrogenic flavonoids using a recombinant yeast strain and a modified MCF7 cell proliferation assay. Chem Res Toxicol, 11, 622-9.
9. Cano A, Garcia-Perez MA, Tarin JJ (2010). Isoflavones and cardiovascular disease. Maturitas, 67, 219-26.
10. Cassidy A, Bingham S, Setchell KD (1994). Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr, 60, 333-40.
11. Cederroth CR, Nef S (2009). Soy, phytoestrogens and metabolism: a review. Mol Cell Endocrinol, 304, 30-42.
12. Celec P, Ostatnikova D, Caganova M, et al (2005). Endocrine and cognitive effects of short-time soybean consumption in women. Gynecol Obstet Invest, 59, 62-6.
13. Dillingham BL, McVeigh BL, Lampe JW, et al (2007). Soy protein isolates of varied isoflavone content do not influence serum thyroid hormones in healthy young men. Thyroid, 17, 131-7.
14. Doerge DR, Chang HC (2002). Inactivation of thyroid peroxidase by soy isoflavones, in vitro and in vivo. J Chromatogr B Analyt Technol Biomed Life Sci, 777, 269-79.
15. Dong JY, Qin LQ (2011). Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies. Breast Cancer Res Treat, 125, 315-23.
16. Duncan AM, Phipps WR, Kurzer MS (2003). Phyto-oestrogens. Best Pract Res Clin Endocrinol Metab, 17, 253-71.
17. Esaki H, Kawakishi S, Morimitsu Y, et al (1999). New potent antioxidative o-dihydroxyisoflavones in fermented Japanese soybean products. Biosci Biotechnol Biochem, 63, 1637-9.
18. Franke AA, Custer LJ (1994). High-performance liquid chromatographic assay of isoflavonoids and coumestrol from human urine. J Chromatogr B Biomed Appl, 662, 47-60.
19. Furspan PB, Freedman RR (1998). Effect of modulators of protein tyrosine kinase activity on gender-related differences in vascular reactivity at reduced temperature. J Cardiovasc Pharmacol, 32, 728-35.
20. Hooper L, Ryder JJ, Kurzer MS, et al (2009). Effects of soy protein and isoflavones on circulating hormone concentrations in pre-and post-menopausal women: a systematic review and meta-analysis. Hum Reprod Update, 15, 423-40.
21. Horn-Ross PL, Barnes S, Lee M, et al (2000). Assessing phytoestrogen exposure in epidemiologic studies: development of a database (United States). Cancer Causes Control, 11, 289-98.
22. Jones DJ, Lim CK, Ferry DR, et al (1998). Determination of quercetin in human plasma by HPLC with spectrophotometric or electrochemical detection. Biomed Chromatogr, 12, 232-5.
23. Kang HB, Zhang YF, Yang JD, et al (2012). Study on soy isoflavone consumption and risk of breast cancer and survival. Asian Pac J Cancer Prev, 13, 995-8.
24. Kim J (2008). Protective effects of Asian dietary items on cancers-soy and ginseng. Asian Pac J Cancer Prev, 9, 543-8.
25. Kim J, Kang M, Lee JS, et al (2011). Fermented and non-fermented soy food consumption and gastric cancer in Japanese and Korean populations: a meta-analysis of observational studies. Cancer Sci, 102, 231-44.
26. King RA, Broadbent JL, Head RJ (1996). Absorption and excretion of the soy isoflavone genistein in rats. J Nutr, 126, 176-82.
27. Klejdus B, Mikelova R, Petrlova J, et al (2005). Evaluation of isoflavone aglycon and glycoside distribution in soy plants and soybeans by fast column high-performance liquid chromatography coupled with a diode-array detector. J Agric Food Chem, 53, 5848-52.
28. Ko KP, Park SK, Park B, et al (2010). Isoflavones from phytoestrogens and gastric cancer risk: a nested case-control study within the Korean Multicenter Cancer Cohort. Cancer Epidemiol Biomarkers Prev, 19, 1292-300.
29. Kuiper GG, Carlsson B, Grandien K, et al (1997). Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology, 138, 863-70.
30. Kuiper GG, Enmark E, Pelto-Huikko M, et al (1996). Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA, 93, 5925-30.
31. Kuiper GG, Lemmen JG, Carlsson B, et al (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology, 139, 4252-63.
32. Kulling SE, Honig DM, Metzler M (2001). Oxidative metabolism of the soy isoflavones daidzein and genistein in humans in vitro and in vivo. J Agric Food Chem, 49, 3024-33.
33. Kulling SE, Honig DM, Simat TJ, et al (2000). Oxidative in vitro metabolism of the soy phytoestrogens daidzein and genistein. J Agric Food Chem, 48, 4963-72.
34. Kulling SE, Lehmann L, Metzler M (2002). Oxidative metabolism and genotoxic potential of major isoflavone phytoestrogens. J Chromatogr B Analyt Technol Biomed Life Sci, 777, 211-8.
35. Kurzer MS, Xu X (1997). Dietary phytoestrogens. Annu Rev Nutr, 17, 353-81.
36. Kwon DY, Daily JW 3rd, Kim HJ, et al (2010). Antidiabetic effects of fermented soybean products on type 2 diabetes. Nutr Res, 30, 1-13.
37. Lampe JW, Karr SC, Hutchins AM, et al (1998). Urinary equol excretion with a soy challenge: influence of habitual diet. Proc Soc Exp Biol Med, 217, 335-9.
38. Li SH, Liu XX, Bai YY, et al (2010). Effect of oral isoflavone supplementation on vascular endothelial function in postmenopausal women: a meta-analysis of randomized placebo-controlled trials. Am J Clin Nutr, 91, 480-6.
39. Liggins J, Bluck LJ, Runswick S, et al (2000). Daidzein and genistein contents of vegetables. Br J Nutr, 84, 717-25.
40. Mathias K, Ismail B, Corvalan CM, et al (2006). Heat and pH effects on the conjugated forms of genistin and daidzin isoflavones. J Agric Food Chem, 54, 7495-502.
41. Minatoya M, Kutomi G, Asakura S, et al (2013). Equol, adiponectin, insulin levels and risk of breast cancer. Asian Pac J Cancer Prev, 14, 2191-9.
42. Mortensen A, Kulling SE, Schwartz H, et al (2009). Analytical and compositional aspects of isoflavones in food and their biological effects. Mol Nutr Food Res, 53, 266-309.
43. Morton MS, Arisaka O, Miyake N, et al (2002). Phytoestrogen concentrations in serum from Japanese men and women over forty years of age. J Nutr, 132, 3168-71.
44. Nakajima N, Nozaki N, Ishihara K, et al (2005). Analysis of isoflavone content in tempeh, a fermented soybean, and preparation of a new isoflavone-enriched tempeh. J Biosci Bioeng, 100, 685-7.
45. Pase MP, Grima NA, Sarris J (2011). The effects of dietary and nutrient interventions on arterial stiffness: a systematic review. Am J Clin Nutr, 93, 446-54.
46. Patisaul HB, Jefferson W (2010). The pros and cons of phytoestrogens. Front Neuroendocrinol, 31, 400-19.
47. Pillow PC, Duphorne CM, Chang S, et al (1999). Development of a database for assessing dietary phytoestrogen intake. Nutr Cancer, 33, 3-19.
48. Pilsakova L, Riecansky I, Jagla F (2010). The physiological actions of isoflavone phytoestrogens. Physiol Res, 59, 651-64.
49. Piontek M, Hengels KJ, Porschen R, et al (1993). Antiproliferative effect of tyrosine kinase inhibitors in epidermal growth factor-stimulated growth of human gastric cancer cells. Anticancer Res, 13, 2119-23.
50. Prasad S, Phromnoi K, Yadav VR, et al (2010). Targeting inflammatory pathways by flavonoids for prevention and treatment of cancer. Planta Med, 76, 1044-63.
51. Qin LQ, Xu JY, Wang PY, et al (2006). Soyfood intake in the prevention of breast cancer risk in women: a meta-analysis of observational epidemiological studies. J Nutr Sci Vitaminol (Tokyo), 52, 428-36.
52. Rakosky J (1975). Soy protein in foods: their use and regulations in the U.S. J Am Oil Chem Soc, 52, 272-4.
53. Ricci E, Cipriani S, Chiaffarino F, et al (2010). Effects of soy isoflavones and genistein on glucose metabolism in perimenopausal and postmenopausal non-Asian women: a meta-analysis of randomized controlled trials. Menopause, 17, 1080-6.
54. Sakai T, Kogiso M (2008). Soy isoflavones and immunity. J Med Invest, 55, 167-73.
55. Setchell KD (1998). Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr, 68, 1333-46.
56. Setchell KD, Cassidy A (1999). Dietary isoflavones: biological effects and relevance to human health. J Nutr, 129, 758-67.
57. Sfakianos J, Coward L, Kirk M, et al (1997). Intestinal uptake and biliary excretion of the isoflavone genistein in rats. J Nutr, 127, 1260-8.
58. Shimazu T, Inoue M, Sasazuki S, et al (2011). Plasma isoflavones and the risk of lung cancer in women: a nested case-control study in Japan. Cancer Epidemiol Biomarkers Prev, 20, 419-27.
59. Shor D, Sathyapalan T, Atkin SL, et al (2012). Does equol production determine soy endocrine effects? Eur J Nutr, 51, 389-98.
60. Sugiyama Y, Masumori N, Fukuta F, et al (2013). Influence of isoflavone intake and equol-producing intestinal flora on prostate cancer risk. Asian Pac J Cancer Prev, 14, 1-4.
61. Taku K, Melby MK, Takebayashi J, et al (2010). Effect of soy isoflavone extract supplements on bone mineral density in menopausal women: meta-analysis of randomized controlled trials. Asia Pac J Clin Nutr, 19, 33-42.
62. Thomas JM, Lutz SF (2001). Soy protein lowers fat and saturated fat in school lunch beef and pork entrees. J Am Diet Assoc, 101, 461-3.
63. Tikkanen MJ, Wahala K, Ojala S, et al (1998). Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc Natl Acad Sci USA, 95, 3106-10.
64. van Pelt AM, de Rooij DG, van der Burg B, et al (1999). Ontogeny of estrogen receptor-beta expression in rat testis. Endocrinology, 140, 478-83.
65. Verkasalo PK, Appleby PN, Allen NE, et al (2001). Soya intake and plasma concentrations of daidzein and genistein: validity of dietary assessment among eighty British women (Oxford arm of the European Prospective Investigation into Cancer and Nutrition). Br J Nutr, 86, 415-21.
66. Wahala K, Rasku S, Parikka K (2002). Deuterated phytoestrogen flavonoids and isoflavonoids for quantitation. J Chromatogr B Analyt Technol Biomed Life Sci, 777, 111-22.
67. Wang CC, Prasain JK, Barnes S (2002). Review of the methods used in the determination of phytoestrogens. J Chromatogr B Analyt Technol Biomed Life Sci, 777, 3-28.
68. Wang GJ, Lapcik O, Hampl R, et al (2000). Time-resolved fluoroimmunoassay of plasma daidzein and genistein. Steroids, 65, 339-48.
69. Wilkinson AP, Wahala K, Williamson G (2002). Identification and quantification of polyphenol phytoestrogens in foods and human biological fluids. J Chromatogr B Analyt Technol Biomed Life Sci, 777, 93-109.
70. Wiseman H, Casey K, Clarke DB, et al (2002). Isoflavone aglycon and glucoconjugate content of high-and low-soy U.K. foods used in nutritional studies. J Agric Food Chem, 50, 1404-10.
71. Wu Q, Wang M, Simon JE (2004). Analytical methods to determine phytoestrogenic compounds. J Chromatogr B Analyt Technol Biomed Life Sci, 812, 325-55.
72. Xu X, Harris KS, Wang HJ, et al (1995). Bioavailability of soybean isoflavones depends upon gut microflora in women. J Nutr, 125, 2307-15.
73. Yakimchuk K, Jondal M, Okret S (2013). Estrogen receptor alpha and beta in the normal immune system and in lymphoid malignancies. Mol Cell Endocrinol, 375, 121-9.
74. Yan L, Spitznagel EL (2009). Soy consumption and prostate cancer risk in men: a revisit of a meta-analysis. Am J Clin Nutr, 89, 1155-63.
75. Yu O, Jung W, Shi J, et al (2000). Production of the isoflavones genistein and daidzein in non-legume dicot and monocot tissues. Plant Physiol, 124, 781-94.
76. Yu X, Zhu J, Mi M, et al (2012). Anti-angiogenic genistein inhibits VEGF-induced endothelial cell activation by decreasing PTK activity and MAPK activation. Med Oncol, 29, 349-57.
77. Zhang YF, Kang HB, Li BL, et al (2012). Positive effects of soy isoflavone food on survival of breast cancer patients in China. Asian Pac J Cancer Prev, 13, 479-82.
78. Zhu YY, Zhou L, Jiao SC, et al (2011). Relationship between soy food intake and breast cancer in China. Asian Pac J Cancer Prev, 12, 2837-40.